Circulatory response to exercise relative to oxygen uptake assessed in the follow‐up of patients with fatty acid beta‐oxidation disorders
Journal of Inherited Metabolic Disease · 2025
DOI: 10.1002/jimd.12819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Apolline Imbard und 17 weiteren Autor:innen. Beteiligte Einrichtung: Service de Biochimie, Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Hauptthemen laut MEDLINE: Oxygen Consumption, Exercise, Carnitine, Lipid Metabolism, Inborn Errors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ultragenyx, Association Française contre les Myopathies, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Patients with fatty acid oxidation disorders (FAODs) experience muscle symptoms due to impaired ATP metabolism and the toxicity of accumulated mitochondrial FAO substrates or intermediates, especially during catabolic states. A major issue is the absence of specific and sensible biomarkers to evaluate metabolic equilibrium. The relationship between cardiac output (Q) and oxygen consumption (VO 2 ) during incremental exercise (dQ/dVO 2 ) provides an indirect surrogate of mitochondrial function. A high dQ/dVO 2 slope indicates impaired oxidative phosphorylation in skeletal muscle during exercise. Our study aimed to evaluate dQ/dVO 2 as a potential marker of the severity of FAODs. We retrospectively collected clinical, laboratory parameters and treatment data for FAOD patients over 6 years old, including a disease severity score, plasma acylcarnitines and cardiopulmonary exercise tests with Q measurement via thoracic bioelectrical impedance. FAO flux was measured in whole blood and in myoblasts when available. We included 27 FAOD patients followed from 2015 to 2022, with deficiencies in LCHAD ( n = 10), CPT2 ( n = 6), VLCAD ( n = 7), or MADD ( n = 4). CPT2 deficient patients with severe scores had the highest C18:1‐, C16‐, C18‐acylcarnitines, and dQ/dVO 2 . In these patients, dQ/dVO 2 was positively correlated with C18:1, C16, and C18 acylcarnitines. In a linear multivariate regression model, dQ/dVO 2 was significantly associated with the severity score (B = 0.831, p = 0.008) and triheptanoin treatment (B = −0.547, p = 0.025). dQ/dVO 2 and plasma long‐chain acylcarnitines might be useful to monitor CPT2D, as these parameters associate with our clinical severity score and could reflect altered mitochondrial functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Biochimie, Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
- Université Paris-Saclay, CEA, Département Médicaments et Technologies pour la Santé, Gif-sur-Yvette, France.
- INSERM U1151, Institut Necker Enfants-Malades (INEM), Paris, France.
- Université Paris Cité, INSERM, Paris, France.
- Service de Neurologie, CHU Paris IdF Ouest - Hôpital Raymond Poincaré, APHP, Garches, France.
- Centre de référence des maladies héréditaires du métabolisme, Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Institut Imagine, Filière G2M, MetabERN, Paris, France.
ORCID-Profile: Apolline Imbard
Förderung
- Ultragenyx
- Association Française contre les Myopathies
- Agence Nationale de la Recherche
- Fondation Jerome Lejeune
- Fondation Tango2
- Ultragenyx Pharmaceutical
- French Muscular Dystrophy Association
Zitieren
APA
Imbard, A., de Calbiac, H., Le Guillou, E., Laforêt, P., Schiff, M., Brassier, A., Thevenet, E., Pontoizeau, C., Lefrère, B., Ottolenghi, C., Lebigot, E., Gaignard, P., Gobin, S., Acquaviva-Bourdain, C., Benoist, J. F., Tuchmann-Durand, C., Legendre, A., & de Lonlay, P. (2025). Circulatory response to exercise relative to oxygen uptake assessed in the follow‐up of patients with fatty acid beta‐oxidation disorders. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12819
Vancouver
Imbard A, de Calbiac H, Le Guillou E, Laforêt P, Schiff M, Brassier A, et al. Circulatory response to exercise relative to oxygen uptake assessed in the follow‐up of patients with fatty acid beta‐oxidation disorders. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.12819
BibTeX
@article{Imbard2025,
author = {Imbard, Apolline and de Calbiac, Hortense and Le Guillou, Edouard and Laforêt, Pascal and Schiff, Manuel and Brassier, Anaïs and Thevenet, Elise and Pontoizeau, Clément and Lefrère, Bertrand and Ottolenghi, Chris and Lebigot, Elise and Gaignard, Pauline and Gobin, Stéphanie and Acquaviva-Bourdain, Cécile and Benoist, Jean-François and Tuchmann-Durand, Caroline and Legendre, Antoine and de Lonlay, Pascale},
title = {Circulatory response to exercise relative to oxygen uptake assessed in the follow‐up of patients with fatty acid beta‐oxidation disorders},
journal = {Journal of Inherited Metabolic Disease},
year = {2025},
doi = {10.1002/jimd.12819}
}
EUVIMED